Huons Global Co., Ltd. (084110.KQ)
KRW 46750.0
(-0.53%)
KRW 46750.0
(-0.53%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 121.81 Billion KRW | 8.26% |
| 2022 | 112.52 Billion KRW | 11.56% |
| 2021 | 100.86 Billion KRW | 15.08% |
| 2020 | 87.64 Billion KRW | 27.89% |
| 2019 | 68.53 Billion KRW | 28.44% |
| 2018 | 53.36 Billion KRW | 13.4% |
| 2017 | 47.05 Billion KRW | 28.0% |
| 2016 | 36.76 Billion KRW | 28.86% |
| 2015 | 28.52 Billion KRW | 3.86% |
| 2014 | 27.46 Billion KRW | 23.44% |
| 2013 | 22.25 Billion KRW | 16.03% |
| 2012 | 19.17 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 136.13 Billion KRW | 7.22% |
| 2024 Q1 | 126.97 Billion KRW | 4.23% |
| 2023 FY | 121.81 Billion KRW | 8.26% |
| 2023 Q3 | 131.06 Billion KRW | -0.75% |
| 2023 Q2 | 132.05 Billion KRW | 4.29% |
| 2023 Q1 | 126.62 Billion KRW | 12.53% |
| 2023 Q4 | 121.81 Billion KRW | -7.06% |
| 2022 Q4 | 112.52 Billion KRW | 6.59% |
| 2022 Q1 | 103.14 Billion KRW | 2.25% |
| 2022 Q2 | 104.45 Billion KRW | 1.27% |
| 2022 Q3 | 105.56 Billion KRW | 1.07% |
| 2022 FY | 112.52 Billion KRW | 11.56% |
| 2021 Q1 | 92.94 Billion KRW | 6.04% |
| 2021 Q2 | 100.76 Billion KRW | 8.41% |
| 2021 Q3 | 99.74 Billion KRW | -1.01% |
| 2021 Q4 | 100.86 Billion KRW | 1.13% |
| 2021 FY | 100.86 Billion KRW | 15.08% |
| 2020 FY | 87.64 Billion KRW | 27.89% |
| 2020 Q1 | 74.62 Billion KRW | 8.89% |
| 2020 Q3 | 86.36 Billion KRW | 3.18% |
| 2020 Q4 | 87.64 Billion KRW | 1.48% |
| 2020 Q2 | 83.7 Billion KRW | 12.16% |
| 2019 FY | 68.53 Billion KRW | 28.44% |
| 2019 Q2 | 58.88 Billion KRW | 5.1% |
| 2019 Q4 | 68.53 Billion KRW | 12.38% |
| 2019 Q1 | 56.03 Billion KRW | 5.01% |
| 2019 Q3 | 60.98 Billion KRW | 3.56% |
| 2018 Q2 | 48.44 Billion KRW | 1.49% |
| 2018 Q4 | 53.36 Billion KRW | 3.8% |
| 2018 Q3 | 51.4 Billion KRW | 6.1% |
| 2018 Q1 | 47.73 Billion KRW | 1.45% |
| 2018 FY | 53.36 Billion KRW | 13.4% |
| 2017 Q1 | 40.59 Billion KRW | 10.42% |
| 2017 Q2 | 45.42 Billion KRW | 11.91% |
| 2017 Q3 | 44.9 Billion KRW | -1.15% |
| 2017 FY | 47.05 Billion KRW | 28.0% |
| 2017 Q4 | 47.05 Billion KRW | 4.79% |
| 2016 Q1 | 6.27 Billion KRW | -78.01% |
| 2016 FY | 36.76 Billion KRW | 28.86% |
| 2016 Q4 | 36.76 Billion KRW | 9.23% |
| 2016 Q3 | 33.65 Billion KRW | 389.93% |
| 2016 Q2 | 6.86 Billion KRW | 9.49% |
| 2015 FY | 28.52 Billion KRW | 3.86% |
| 2015 Q4 | 28.52 Billion KRW | -6.54% |
| 2015 Q3 | 30.52 Billion KRW | -3.37% |
| 2015 Q2 | 31.58 Billion KRW | 8.72% |
| 2015 Q1 | 29.05 Billion KRW | 5.78% |
| 2014 Q1 | 23.2 Billion KRW | 4.28% |
| 2014 FY | 27.46 Billion KRW | 23.44% |
| 2014 Q3 | 27.09 Billion KRW | 5.39% |
| 2014 Q4 | 27.46 Billion KRW | 1.37% |
| 2014 Q2 | 25.71 Billion KRW | 10.81% |
| 2013 Q2 | 21.18 Billion KRW | 7.63% |
| 2013 Q1 | 19.68 Billion KRW | 2.64% |
| 2013 Q4 | 22.25 Billion KRW | -3.74% |
| 2013 Q3 | 23.11 Billion KRW | 9.11% |
| 2013 FY | 22.25 Billion KRW | 16.03% |
| 2012 FY | 19.17 Billion KRW | 0.0% |
| 2012 Q4 | 19.17 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 20.85 Billion KRW | -484.034% |
| CMG Pharmaceutical Co., Ltd. | 15.87 Billion KRW | -667.322% |
| Celltrion Pharm, Inc. | 100.42 Billion KRW | -21.308% |
| DongKook Pharmaceutical Co., Ltd. | 138.34 Billion KRW | 11.945% |
| Enzychem Lifesciences Corporation | 14.94 Billion KRW | -715.064% |
| Humedix Co., Ltd. | 28.62 Billion KRW | -325.561% |
| Boditech Med Inc. | 31.6 Billion KRW | -285.465% |
| EuBiologics Co., Ltd. | 13.34 Billion KRW | -813.076% |
| FutureChem Co.,Ltd | 1.37 Billion KRW | -8762.707% |
| Huons Co., Ltd. | 76.59 Billion KRW | -59.036% |
| BNC Korea Co., Ltd. | 11.39 Billion KRW | -969.194% |
| AptaBio Therapeutics Inc. | - KRW | -Infinity% |